Jose Laborde, PhD

Senior Biostatistician
Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa FL, United States

Presentation(s):

• 35: Hepatic and Overall Progression-Free Survival after Percutaneous Hepatic Perfusion as First-Line or Second-Line Therapy for Metastatic Uveal Melanoma

  Monday, February 19, 2024
  8:40 AM - 8:50 AM AST